# PCN21 Efficacy and Safety in Previously Untreated, Advanced/Metastatic Renal Cell Carcinoma – a Systematic Literature Review Update

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/pcn21-efficacy-and-safety-in-previously-untreated-advanced-metastatic-renal-cell/

## Facts

| Field | Value |
| --- | --- |
| Author Names | C.W. Kraan,Lisette Nientker,J. May,Bill Malcolm,Flavia Ejzykowicz,Murat Kurt,Danielle S. Chun,S. Branchoux,Su Ann Ho,Jelle A. Spoorendonk |
| Citations | 1 |
| DOI | 10.1016/j.jval.2020.08.158 |
| Fields | Biochemistry, Genetics and Molecular Biology,Economics, Econometrics and Finance,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W3113062706 |
| Type | review |
| Year | 2020 |

## Paper authors

- [Su Ann Ho](https://scholariq.org/researchers/su-ann-ho/)

## Paper journal

- [Value in Health](https://scholariq.org/journals/value-in-health/)

## Paper primary topic

- [Renal cell carcinoma treatment](https://scholariq.org/topics/renal-cell-carcinoma-treatment/)

## Paper topics

- [Renal cell carcinoma treatment](https://scholariq.org/topics/renal-cell-carcinoma-treatment/)
- [Economic and Financial Impacts of Cancer](https://scholariq.org/topics/economic-and-financial-impacts-of-cancer/)
- [Renal and related cancers](https://scholariq.org/topics/renal-and-related-cancers/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.